Annual Total Long Term Liabilities
$77.70 M
-$45.26 M-36.81%
December 31, 2023
Summary
- As of February 7, 2025, PBYI annual total long term liabilities is $77.70 million, with the most recent change of -$45.26 million (-36.81%) on December 31, 2023.
- During the last 3 years, PBYI annual total long term liabilities has fallen by -$58.21 million (-42.83%).
- PBYI annual total long term liabilities is now -50.73% below its all-time high of $157.70 million, reached on December 31, 2018.
Performance
PBYI Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$39.24 M
-$12.96 M-24.83%
September 30, 2024
Summary
- As of February 7, 2025, PBYI quarterly total long term liabilities is $39.24 million, with the most recent change of -$12.96 million (-24.83%) on September 30, 2024.
- Over the past year, PBYI quarterly long term liabilities has dropped by -$58.27 million (-59.76%).
- PBYI quarterly long term liabilities is now -78.96% below its all-time high of $186.49 million, reached on March 31, 2019.
Performance
PBYI Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
PBYI Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.8% | -59.8% |
| 3 y3 years | -42.8% | -66.5% |
| 5 y5 years | -50.7% | -66.5% |
PBYI Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.8% | at low | -68.1% | at low |
| 5 y | 5-year | -42.8% | at low | -73.1% | at low |
| alltime | all time | -50.7% | -100.0% | -79.0% | -100.0% |
Puma Biotechnology Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $39.24 M(-24.8%) |
| Jun 2024 | - | $52.20 M(-19.7%) |
| Mar 2024 | - | $64.98 M(-16.4%) |
| Dec 2023 | $77.70 M(-36.8%) | $77.70 M(-20.3%) |
| Sep 2023 | - | $97.50 M(-11.2%) |
| Jun 2023 | - | $109.81 M(-10.2%) |
| Mar 2023 | - | $122.22 M(-0.6%) |
| Dec 2022 | $122.97 M(+2.9%) | $122.97 M(+5.4%) |
| Sep 2022 | - | $116.63 M(-0.4%) |
| Jun 2022 | - | $117.08 M(-1.4%) |
| Mar 2022 | - | $118.75 M(-0.6%) |
| Dec 2021 | $119.44 M(-12.1%) | $119.44 M(-1.2%) |
| Sep 2021 | - | $120.95 M(+30.6%) |
| Jun 2021 | - | $92.63 M(-9.0%) |
| Mar 2021 | - | $101.81 M(-25.1%) |
| Dec 2020 | $135.92 M(+7.4%) | $135.92 M(-5.6%) |
| Sep 2020 | - | $143.95 M(-1.3%) |
| Jun 2020 | - | $145.88 M(+16.1%) |
| Mar 2020 | - | $125.69 M(-0.7%) |
| Dec 2019 | $126.61 M(-19.7%) | $126.61 M(+0.1%) |
| Sep 2019 | - | $126.52 M(+0.1%) |
| Jun 2019 | - | $126.43 M(-32.2%) |
| Mar 2019 | - | $186.49 M(+18.3%) |
| Dec 2018 | $157.70 M(+192.7%) | $157.70 M(+24.2%) |
| Sep 2018 | - | $126.93 M(+0.9%) |
| Jun 2018 | - | $125.79 M(+132.7%) |
| Mar 2018 | - | $54.06 M(+0.3%) |
| Dec 2017 | $53.88 M(+878.8%) | $53.88 M(+890.9%) |
| Sep 2017 | - | $5.44 M(-0.6%) |
| Jun 2017 | - | $5.47 M(-0.6%) |
| Mar 2017 | - | $5.50 M(-0.1%) |
| Dec 2016 | $5.50 M | $5.50 M(+4.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $5.28 M(+9.0%) |
| Jun 2016 | - | $4.85 M(+265.5%) |
| Mar 2016 | - | $1.33 M(-4.8%) |
| Dec 2015 | $1.39 M(+9.8%) | $1.39 M(-4.1%) |
| Sep 2015 | - | $1.45 M(-2.2%) |
| Jun 2015 | - | $1.48 M(+0.9%) |
| Mar 2015 | - | $1.47 M(+15.9%) |
| Dec 2014 | $1.27 M(+13.7%) | $1.27 M(+16.3%) |
| Sep 2014 | - | $1.09 M(-1.4%) |
| Jun 2014 | - | $1.11 M(-9.5%) |
| Mar 2014 | - | $1.22 M(+9.6%) |
| Dec 2013 | $1.12 M(+2.5%) | $1.12 M(-0.6%) |
| Sep 2013 | - | $1.12 M(-1.1%) |
| Jun 2013 | - | $1.14 M(+2.1%) |
| Mar 2013 | - | $1.11 M(+2.2%) |
| Dec 2012 | $1.09 M(+148.1%) | $1.09 M(+30.5%) |
| Sep 2012 | - | $834.80 K(-2.5%) |
| Jun 2012 | - | $855.90 K(+15.1%) |
| Mar 2012 | - | $743.70 K(+69.4%) |
| Dec 2011 | $439.00 K(>+9900.0%) | $439.00 K(>+9900.0%) |
| Sep 2011 | - | $0.00(0.0%) |
| Jun 2011 | - | $0.00(0.0%) |
| Mar 2011 | - | $0.00(0.0%) |
| Dec 2010 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2010 | - | $0.00(0.0%) |
| Jun 2010 | - | $0.00(0.0%) |
| Mar 2010 | - | $0.00(0.0%) |
| Dec 2009 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2009 | - | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) |
| Dec 2008 | $0.00 | $0.00 |
FAQ
- What is Puma Biotechnology annual total long term liabilities?
- What is the all time high annual total long term liabilities for Puma Biotechnology?
- What is Puma Biotechnology annual total long term liabilities year-on-year change?
- What is Puma Biotechnology quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Puma Biotechnology?
- What is Puma Biotechnology quarterly long term liabilities year-on-year change?
What is Puma Biotechnology annual total long term liabilities?
The current annual total long term liabilities of PBYI is $77.70 M
What is the all time high annual total long term liabilities for Puma Biotechnology?
Puma Biotechnology all-time high annual total long term liabilities is $157.70 M
What is Puma Biotechnology annual total long term liabilities year-on-year change?
Over the past year, PBYI annual total long term liabilities has changed by -$45.26 M (-36.81%)
What is Puma Biotechnology quarterly total long term liabilities?
The current quarterly long term liabilities of PBYI is $39.24 M
What is the all time high quarterly long term liabilities for Puma Biotechnology?
Puma Biotechnology all-time high quarterly total long term liabilities is $186.49 M
What is Puma Biotechnology quarterly long term liabilities year-on-year change?
Over the past year, PBYI quarterly total long term liabilities has changed by -$58.27 M (-59.76%)